1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow HER2 Expression: new trials by email Literature Review of HER2 Expression trials Research Report on HER2 Expression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer PET imaging with ⁸⁹Zr-trastuzumab, Blood sampling for pharmacokinetics - Lung Cancer (NSCLC), HER2 Expression | Phase 1 | Recruiting | The Netherlands Cancer Institute | 20 | 2026-10-02 | 2026-10-20 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Blood Specimen Collection (1) · Pharmacokinetics (1) · Positron-Emission Tomography (1)
The Netherlands Cancer Institute (1)
Netherlands (1)